683 Capital Management’s Xynomic Pharmaceuticals Holdings, Inc. Common Stock XYN Stock Holding History

683 Capital Management’s Portfolio XYN Stock Details XYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$34K	–	186
2019 Q2	$34K	Buy	+10,000	New	+$32.5K	﹤0.01%	162

683 Capital Management's XYN Position: Q3 2019 in Review

683 Capital Management sold out of Xynomic Pharmaceuticals Holdings, Inc. Common Stock (XYN) in Q3 2019, closing a stake of 10,000 shares — an estimated $34K sold.

683 Capital Management first reported a position in XYN in Q2 2019 and held it in 1 quarter. The position peaked at $34K in Q2 2019. 0 funds tracked by Wall St. Rank hold XYN as of Q3 2019.

683 Capital Management reported no remaining Xynomic Pharmaceuticals Holdings, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
683 Capital Management sold 10,000 Xynomic Pharmaceuticals Holdings, Inc. Common Stock shares in Q3 2019, an estimated $34K.
683 Capital Management first reported a position in Xynomic Pharmaceuticals Holdings, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
683 Capital Management's Xynomic Pharmaceuticals Holdings, Inc. Common Stock position peaked at $34K in Q2 2019.
0 funds tracked by Wall St. Rank held Xynomic Pharmaceuticals Holdings, Inc. Common Stock as of Q3 2019.

Based on 683 Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.